First information event under Project „Experimental development for creation of decision support application (Danny DSA) for breast and prostate cancer care“

On Wednesday 22nd June 2022, at 15:00 o’clock (Bulgarian time) will be held the first information event, under Project „Experimental development for creation of decision support application (Danny DSA) for breast and prostate cancer care”. The project was approved for funding by Norwegian Financial Mechanism 2014-2021, Programme Business Development, Innovation and SMEs, Bulgaria, Focus area: Welfare Technology.Information on the Norwegian Financial Mechanism 2014-2021 is available online at: https://www.innovasjonnorge.no/en/start-page/eea-norway-grants/Programmes/business-development/Bulgaria/

The information event will be held electronically – via ZOOM conference platform.

To participate on the event, please use the following log-in details:

Topic: First information event, under Project „Experimental development for creation of decision support application (Danny DSA) for breast and prostate cancer care”

Date & Time: 22 June 2022, at 15:00 o’clock, Sofia

Join ZOOM Meeting:

https://us02web.zoom.us/j/81074714660

Language of the event: Bulgarian & English. Event moderator: Rosen Dimitrov

Topic: Project „ Experimental development for creation of decision support application (Danny DSA) for breast and prostate cancer care “is related to:

  • Create a decision support system for breast and prostate cancer care that will reflect and enhance clinical practice guidelines by contrasting them with large-scale semantic and causal analyses of realworld data using advanced AI tools;
  • Propose an open standard for guideline representation and a toolset to convert guidelines into oncology-driven, computer-readable format.
  • Provide patient-centric support tools to be used by breast/prostate cancer patients;
  • Establish a large, real-world dataset in breast/prostate cancer care.

Main objective: Creation of effective and efficient IT solution, which will provide health care specialists with accurate and consistent CPGs for breast and prostate cancer care.

Beneficiary: Sqilline Business Solutions “Ltd

Overall project amount: 774 900 euro (349 000 euro grant support and 425 900 euro own co-financing).

Project start date: 01.03.2022

Project end date: 31.08.2023

 

Supported by the Norway Grants 2014-2021, in the frame of the Programme Business Development,

Innovation and SMEs, Bulgaria.

С финансовата подкрепа на Норвежкия финансов механизъм 2014-2021, в рамките на програма

“Развитие на бизнеса, иновации и МСП в България”.

Share this article:

More News & Highlights

News

Adherence to treatment and decision support technology

Sofia, June 17, 2022 – The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) held its Bulgarian Chapter event and Sqilline took an essential part...

Read more...

News

Transforming Clinical Research and Decision Support through Technology

Sofia, June 7, 2022 - Sqilline organized an exclusive health tech event with key stakeholders from the healthcare sector. The hot topic was the launch...

Read more...

News

The healthtech company speeds up R&D in medicine by accelerating patient enrollment in clinical trials with Danny Platform

Sofia, May 11, 2022 –Sqilline has transformed into a Clinical Research Organization (CRO). The company is set to further develop its innovative digital approach in clinical trials...

Read more...